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A bs tr ac t
Background
Previous studies have relied predominantly on the body-mass index (BMI, the weight 
in kilograms divided by the square of the height in meters) to assess the association 
of adiposity with the risk of death, but few have examined whether the distribution 
of body fat contributes to the prediction of death.
Methods
We examined the association of BMI, waist circumference, and waist-to-hip ratio 
with the risk of death among 359,387 participants from nine countries in the Euro-
pean Prospective Investigation into Cancer and Nutrition (EPIC). We used a Cox 
regression analysis, with age as the time variable, and stratified the models accord-
ing to study center and age at recruitment, with further adjustment for educational 
level, smoking status, alcohol consumption, physical activity, and height.
Results
During a mean follow-up of 9.7 years, 14,723 participants died. The lowest risks of 
death related to BMI were observed at a BMI of 25.3 for men and 24.3 for women. 
After adjustment for BMI, waist circumference and waist-to-hip ratio were strongly 
associated with the risk of death. Relative risks among men and women in the highest 
quintile of waist circumference were 2.05 (95% confidence interval [CI], 1.80 to 2.33) 
and 1.78 (95% CI, 1.56 to 2.04), respectively, and in the highest quintile of waist-to-
hip ratio, the relative risks were 1.68 (95% CI, 1.53 to 1.84) and 1.51 (95% CI, 1.37 to 
1.66), respectively. BMI remained significantly associated with the risk of death in 
models that included waist circumference or waist-to-hip ratio (P<0.001).
Conclusions
These data suggest that both general adiposity and abdominal adiposity are associ-
ated with the risk of death and support the use of waist circumference or waist-to-
hip ratio in addition to BMI in assessing the risk of death.
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A bdominal obesity is more closely associated with the risk of several chronic diseases than is gluteofemoral obesity, and 
large studies have suggested that waist circum-
ference or the waist-to-hip ratio, as indicators of 
abdominal obesity, may be better predictors of 
the risk of disease than the body-mass index 
(BMI, the weight in kilograms divided by the 
square of the height in meters), an indicator of 
general adiposity.1-4 Current guidelines with re-
spect to obesity recommend the measurement of 
waist circumference in persons with a BMI be-
tween 25.0 and 34.9 and propose cutoff points 
for waist circumference of 102 cm in men and 88 
cm in women (and cutoff points for waist-to-hip 
ratio of 1.0 in men and 0.85 in women) to define 
abdominal obesity and to identify persons at risk 
for disease.2 However, less is known about the 
association of waist circumference or waist-to-hip 
ratio with the risk of death.
Most studies that have examined the associa-
tion of both general and abdominal obesity with 
the risk of death5-16 have shown that abdominal 
adiposity is an important predictor of the risk of 
death, but few such studies were conducted in 
Europe.14-16 Large studies in the United States 
and Korea either did not assess waist circumfer-
ence or waist-to-hip ratio17,18 or relied on self-
reports of anthropometric measurements.12,19 We 
therefore evaluated the association of general 
and abdominal adiposity with the risk of death in 
the European Prospective Investigation into Can-




EPIC includes 519,978 men and women who were 
25 to 70 years of age at enrollment (during the 
period from 1992 through 2000) and who were 
recruited predominantly from the general popula-
tion residing in a given geographic area (town or 
province) in 23 centers in 10 European countries 
(Denmark, France, Germany, Greece, Italy, the 
Netherlands, Norway, Spain, Sweden, and the 
United Kingdom) (see Table 1 of the Supplemen-
tary Appendix, available with the full text of this 
article at www.nejm.org).20 Participants gave writ-
ten informed consent, underwent anthropometric 
measurements, and completed a questionnaire 
that asked for information regarding sociodemo-
graphic and lifestyle characteristics, medical histo-
ry, alcohol consumption, and physical activity.20-22 
Approval was obtained from the ethics review 
board of the International Agency for Research 
on Cancer and the local review boards of the par-
ticipating institutions. The association of anthro-
pometric measures with the risk of death has pre-
viously been reported in two cohorts that are part 
of EPIC — those in Denmark and Malmö, 
Sweden.15,16 These participants are included in the 
present analysis with longer follow-up periods.
We excluded 2088 participants who withdrew 
from the study and for whom there was no follow-
up information on vital status. Furthermore, the 
cohort in Umeå, Sweden (25,720 persons), was 
excluded because the information on leisure-time 
physical activity provided on the questionnaire 
completed by this cohort was not compatible with 
that provided on the other EPIC questionnaires. 
We also excluded subjects for whom data on 
measured height or weight were missing — all 
the participants from the Norwegian cohorts 
(37,205 persons), 52,872 participants from the 
French cohorts, and 8451 from other cohorts. In 
addition, we excluded 1441 participants with 
missing questionnaire data and, to reduce the 
effect of implausible extreme values, 7659 partici-
pants who were in the top or bottom 1% of the 
total cohort with respect to the ratio of energy 
intake to estimated energy requirement.23 Final-
ly, to avoid confounding by preexisting chronic 
diseases, we excluded 25,155 participants who 
reported a history of cancer, heart disease, or 
stroke at baseline. Thus, the final study included 
359,387 participants.
Assessment of End Points
Vital status and the cause and date of death were 
ascertained by means of record linkages with 
cancer registries, boards of health, and death in-
dexes (in the case of Denmark, Italy, the Nether-
lands, Spain, Sweden, and the United Kingdom) 
or by active follow-up (in the case of Germany, 
Greece, and France). Active follow-up included in-
quiries by mail or telephone to participants, mu-
nicipal registries, regional health departments, 
physicians, and hospitals. Data on death were 
coded according to the rules of the International 
Classification of Diseases, 10th Revision (ICD-10). The 
code for the underlying cause of death was used, 
classified as circulatory (ICD-10 codes I00 through 
I99), neoplasms (C00 through D48), respiratory 
(J00 through J99 [i.e., not including neoplasms of 
the respiratory organs]), other, or not reported.
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Assessment of Anthropometric Data
Weight and height were measured with subjects 
not wearing shoes.24 Waist circumference was 
measured either at the narrowest circumference 
of the torso or at the midpoint between the lower 
ribs and the iliac crest. Hip circumference was 
measured horizontally at the level of the largest 
lateral extension of the hips or over the buttocks. 
Each participant’s body weight and waist and hip 
circumferences were corrected for the clothing 
worn during measurement in order to reduce het-
erogeneity due to protocol differences among cen-
ters (see Appendix 1 in the Supplementary Appen-
dix for a detailed description). Measurements of 
waist circumference and waist-to-hip ratio were 
missing for 3833 participants (1.07%) and 6466 
participants (1.80%), respectively. These partici-
pants were excluded from analyses of these vari-
ables.
Statistical Analysis
Associations between anthropometric variables 
and the risk of death were analyzed with the use 
of a Cox regression model, with age as the under-
lying time variable. We divided the cohort into 
categories of BMI that were similar to those used 
for the National Institutes of Health–AARP cohort 
(<18.5, 18.5 to <21.0, 21.0 to <23.5, 23.5 to <25.0, 
25.0 to <26.5, 26.5 to <28.0, 28.0 to <30.0, 30.0 
to <35.0, and ≥35.0).17 These categories incorpo-
rate current definitions of underweight (BMI, 
<18.5), normal weight (18.5 to <25.0), overweight 
(25.0 to <30.0), and obesity (≥30.0).2 The likeli-
hood-ratio test was used to assess the statistical 
significance of an asssociation between BMI and 
the risk of death. In addition, subjects were 
grouped into sex-specific quintiles according to 
waist circumference and waist-to-hip ratio. Tests 
for trend in relative risks were based on medians 
across quintiles. The relationships were also eval-
uated with the use of nonparametric restricted 
cubic splines,25 with 4 knots defined at the 5th, 
25th, 75th, and 95th percentiles of the anthropo-
metric measurements. All models were stratified 
according to age at recruitment and according to 
study center to reduce violations of the propor-
tional-hazards assumption. The analysis was fur-
ther adjusted for smoking status, educational level, 
alcohol consumption, physical activity, and height. 
Models for waist circumference and waist-to-hip 
ratio were also adjusted for BMI.
Subgroup analyses were conducted according 
to strata of smoking status and age at recruit-
ment. Waist circumference and waist-to-hip ratio 
were also examined across sex-specific BMI thirds. 
Tests for interaction were performed with the 
likelihood-ratio test of models with and without 
interaction terms. Differences according to the 
cause of death were examined in competing risk 
models.26 Similar analyses examined differences 
between models that censored follow-up time 
after 5 years and models that excluded person-
time and events from the first 5 years.
To assess performance in the prediction of 
death, we calculated the C statistic, the Hosmer–
Lemeshow statistic, Nagelkerke’s generalized-
model R2 statistic, and net reclassification index es 
for a follow-up time of 5 years (available for 98.2% 
of the cohort), using logistic-regression models, 
adjusted for the covariates described above.27-31
All P values presented are two-tailed, and 
P values of less than 0.05 were considered to in-
dicate statistical significance. Analyses were per-
formed with the use of SAS software, version 9.1 
(SAS Institute).
R esult s
Characteristics of Study Participants
During a mean (±SD) follow-up of 9.7±2.0 years, 
14,723 of the initial 359,387 participants died 
(5429 from neoplasms, 3443 from circulatory 
causes, 637 from respiratory causes, 2209 from 
other causes, and 3005 from unspecified causes; 
see Table 1 in the Supplementary Appendix). The 
mean age at baseline was 51.5±10.4 years; 65.4% 
of the participants were women. Participants with 
a higher BMI, as compared with those who had a 
lower BMI, were older, were less likely to be cur-
rent smokers, and had a lower educational level 
(see Table 2 in the Supplementary Appendix). Alco-
hol consumption was positively related to BMI 
among men but inversely related to BMI among 
women. Pearson partial-correlation coefficients, 
adjusted for age and study center, for the correla-
tion of BMI with waist circumference and with 
waist-to-hip ratio were 0.85 and 0.55, respectively, 
among men and 0.84 and 0.38, respectively, among 
women (P<0.001 for all correlations).
Associations with the Risk of Death
There was a significant nonlinear association of 
BMI with the risk of death, with the lowest risks 
at a BMI of 25.3 among men and 24.3 among 
women, and increased risks in the lower and up-
per BMI categories (Table 1 and Fig. 1). These 
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Table 1. Relative Risk of Death According to BMI among Men and Women in the European Prospective Investigation into Cancer and Nutrition.*
Relative Risk BMI
<18.5 18.5 to <21.0 21.0 to <23.5 23.5 to <25.0 25.0 to <26.5
Men
Person-years 4504 45,494 176,701 188,823 215,370
Deaths (no.) 92 390 1071 1144 1209
Overall relative risk (95% CI)
Crude§ 2.86 (2.30–3.57) 1.64 (1.46–1.84) 1.08 (0.99–1.17) 1.00 0.90 (0.83–0.98)
Adjusted¶ 2.30 (1.84–2.86) 1.39 (1.24–1.57) 1.03 (0.94–1.12) 1.00 0.91 (0.84–0.99)
Relative risk by subgroup (95% CI)¶
Smoking status‖
Never smoked 1.19 (0.54–2.62) 1.25 (0.93–1.67) 0.97 (0.80–1.07) 1.00 0.89 (0.73–1.07)
Former smoker 2.18 (1.39–3.41) 1.69 (1.34–2.13) 1.05 (0.90–1.22) 1.00 0.95 (0.83–1.09)
Current smoker 2.75 (2.09–3.63) 1.39 (1.19–1.63) 1.03 (0.91–1.17) 1.00 0.86 (0.76–0.98)
Age 
<55 yr 4.43 (3.01–6.54) 1.66 (1.33–2.07) 1.07 (0.90–1.26) 1.00 1.09 (0.93–1.28)
55 to <65 yr 2.27 (1.55–3.33) 1.30 (1.09–1.55) 1.03 (0.91–1.17) 1.00 0.83 (0.73–0.93)
≥65 yr 1.56 (1.07–2.27) 1.32 (1.06–1.65) 1.00 (0.85–1.17) 1.00 0.91 (0.77–1.06)
Follow-up**
≤5 yr 3.08 (2.26–4.20) 1.29 (1.06–1.57) 1.02 (0.89–1.17) 1.00 0.84 (0.73–0.96)
>5 yr 1.78 (1.30–2.45) 1.45 (1.25–1.68) 1.03 (0.93–1.15) 1.00 0.95 (0.86–1.05)
Cause of death
Neoplasms 1.20 (0.73–1.97) 1.27 (1.03–1.55) 0.92 (0.80–1.07) 1.00 0.82 (0.72–0.95)
Circulatory 1.84 (1.19–2.87) 1.05 (0.81–1.36) 0.97 (0.81–1.15) 1.00 0.95 (0.80–1.12)
Respiratory 6.53 (3.56–11.97) 2.29 (1.46–3.59) 1.21 (0.84–1.76) 1.00 0.66 (0.44–0.99)
Other 4.67 (2.98–7.31) 2.02 (1.54–2.66) 1.30 (1.05–1.60) 1.00 0.99 (0.80–1.22)
Women
Person-years 41,623 286,794 574,777 344,116 287,155
Deaths (no.) 167 714 1397 953 865
Overall relative risk (95% CI)
Crude§ 1.96 (1.66–2.32) 1.27 (1.15–1.40) 1.01 (0.93–1.10) 1.00 1.01 (0.92–1.11)
Adjusted¶ 1.71 (1.44–2.01) 1.22 (1.10–1.34) 1.00 (0.92–1.09) 1.00 1.01 (0.92–1.11)
Relative risk by subgroup (95% CI)¶
Smoking status‖
Never smoked 1.44 (1.08–1.92) 1.09 (0.93–1.27) 1.00 (0.88–1.13) 1.00 1.00 (0.87–1.15)
Former smoker 1.47 (0.98–2.20) 1.01 (0.82–1.25) 0.85 (0.72–1.00) 1.00 0.94 (0.79–1.12)
Current smoker 2.29 (1.79–2.95) 1.53 (1.29–1.81) 1.14 (0.98–1.33) 1.00 1.07 (0.90–1.28)
Age 
<55 yr 1.69 (1.26–2.27) 1.15 (0.97–1.37) 0.96 (0.82–1.11) 1.00 1.04 (0.87–1.25)
55 to <65 yr 1.92 (1.49–2.48) 1.26 (1.08–1.47) 1.01 (0.89–1.15) 1.00 0.97 (0.84–1.12)
≥65 yr 1.40 (1.01–1.96) 1.28 (1.05–1.56) 1.04 (0.89–1.23) 1.00 1.04 (0.87–1.24)
Follow-up **
≤5 yr 2.01 (1.51–2.68) 1.17 (0.97–1.40) 1.07 (0.92–1.24) 1.00 0.99 (0.84–1.16)
>5 yr 1.56 (1.27–1.92) 1.24 (1.10–1.40) 0.97 (0.88–1.08) 1.00 1.02 (0.91–1.14)
Cause of death
Neoplasms 1.16 (0.85–1.58) 1.17 (1.00–1.36) 0.98 (0.86–1.11) 1.00 1.00 (0.87–1.15)
Circulatory 1.09 (0.69–1.75) 1.10 (0.87–1.41) 1.01 (0.83–1.22) 1.00 1.13 (0.92–1.39)
Respiratory 4.74 (2.60–8.64) 1.70 (1.05–2.76) 1.29 (0.85–1.97) 1.00 0.64 (0.37–1.11)
Other 2.97 (2.07–4.27) 1.43 (1.10–1.84) 1.11 (0.89–1.39) 1.00 1.02 (0.79–1.31)
*  BMI denotes body-mass index, which is the weight in kilograms divided by the square of the height in meters. CI denotes confidence 
 interval.
†  P values, based on the likelihood-ratio test, are for comparisons of the model that included BMI categories with the model that did not in-
clude BMI categories, with 8 degrees of freedom.
‡  P values, based on the likelihood-ratio test, are for comparisons of the model that included interaction terms between BMI and the stratifi-
cation variable with the model that did not include these interaction terms (with 16 degrees of freedom each for smoking status and age, 
24 degrees of freedom for cause of death, and 8 degrees of freedom each for preexisting disease and length of follow-up); for cause of 
death and length of follow-up, the data-augmentation method described by Lunn and McNeil was used.26
§  The crude relative risk was calculated with the use of Cox proportional-hazards regression, with age as the underlying time variable and 
stratification according to center and age at recruitment.
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BMI P Value† P Value for Interaction‡
26.5 to <28.0 28.0 to <30.0 30.0 to <35.0 ≥35.0
186,758 177,458 157,899 24,794
1118 1212 1256 313
0.95 (0.88–1.03) 1.09 (1.01–1.18) 1.28 (1.18–1.39) 2.06 (1.81–2.34) <0.001
0.96 (0.88–1.04) 1.08 (1.00–1.17) 1.24 (1.14–1.35) 1.94 (1.71–2.20) <0.001
0.09
1.05 (0.86–1.27) 1.21 (1.01–1.47) 1.48 (1.22–1.79) 2.78 (2.09–3.71) <0.001
1.01 (0.88–1.15) 1.16 (1.01–1.32) 1.39 (1.21–1.59) 2.10 (1.71–2.58) <0.001
0.91 (0.80–1.03) 0.99 (0.87–1.13) 1.11 (0.98–1.26) 1.66 (1.34–2.05) <0.001
0.004
0.91 (0.77–1.08) 1.16 (0.98–1.37) 1.41 (1.20–1.66) 1.98 (1.55–2.53) <0.001
0.97 (0.86–1.09) 1.06 (0.94–1.19) 1.22 (1.08–1.37) 2.02 (1.69–2.41) <0.001
0.99 (0.84–1.16) 1.06 (0.90–1.24) 1.10 (0.93–1.30) 1.63 (1.21–2.19) <0.001
0.13
0.93 (0.81–1.07) 1.06 (0.93–1.21) 1.16 (1.02–1.33) 1.71 (1.38–2.11) <0.001
0.98 (0.88–1.09) 1.09 (0.99–1.21) 1.29 (1.16–1.43) 2.09 (1.78–2.46) <0.001
<0.001
0.91 (0.79–1.04) 0.93 (0.81–1.07) 0.94 (0.82–1.09) 1.24 (0.97–1.60) 0.002
1.01 (0.85–1.20) 1.28 (1.09–1.51) 1.62 (1.38–1.90) 2.70 (2.13–3.42) <0.001
0.74 (0.49–1.10) 0.74 (0.50–1.11) 0.90 (0.60–1.34) 1.65 (0.90–3.03) <0.001
0.94 (0.75–1.17) 1.12 (0.90–1.40) 1.26 (1.01–1.57) 2.15 (1.57–2.96) <0.001
221,840 209,676 250,494 85,953
745 734 926 417
1.08 (0.98–1.19) 1.10 (1.00–1.21) 1.18 (1.08–1.29) 1.68 (1.49–1.89) <0.001
1.07 (0.97–1.18) 1.11 (1.00–1.22) 1.17 (1.07–1.29) 1.65 (1.46–1.85) <0.001
0.04
1.12 (0.98–1.30) 1.12 (0.97–1.29) 1.25 (1.09–1.43) 1.80 (1.53–2.12) <0.001
0.91 (0.75–1.11) 0.94 (0.77–1.14) 0.95 (0.79–1.16) 1.49 (1.16–1.91) 0.002
1.21 (1.00–1.46) 1.30 (1.07–1.58) 1.38 (1.14–1.67) 1.60 (1.20–2.13) <0.001
0.79
1.06 (0.87–1.28) 1.16 (0.96–1.41) 1.24 (1.03–1.50) 1.66 (1.31–2.11) <0.001
1.03 (0.89–1.19) 1.16 (1.01–1.33) 1.19 (1.03–1.36) 1.68 (1.42–2.00) <0.001
1.15 (0.96–1.37) 1.00 (0.83–1.21) 1.10 (0.93–1.31) 1.56 (1.24–1.97) 0.002
0.39
1.03 (0.86–1.22) 1.04 (0.87–1.24) 1.10 (0.93–1.30) 1.62 (1.32–1.98) <0.001
1.09 (0.97–1.23) 1.13 (1.01–1.28) 1.21 (1.08–1.35) 1.66 (1.43–1.92) <0.001
<0.001
1.06 (0.91–1.23) 1.21 (1.05–1.40) 1.12 (0.97–1.29) 1.38 (1.14–1.68) 0.002
1.15 (0.92–1.43) 1.24 (1.01–1.54) 1.31 (1.07–1.61) 2.27 (1.78–2.90) <0.001
1.29 (0.80–2.09) 0.83 (0.48–1.44) 1.18 (0.73–1.91) 1.57 (0.83–2.95) <0.001
1.13 (0.87–1.46) 0.95 (0.72–1.26) 1.35 (1.05–1.73) 1.79 (1.30–2.46) <0.001
¶  Multivariable adjusted models were based on the crude model with additional adjustment for smoking status (never smoked, former smoker 
[stopped ≥10 or <10 years ago or time since stopping unknown], current smoker [<15, 15 to 24, or ≥25 cigarettes per day or number unknown], 
or data missing), educational level (no school degree, primary-school degree, technical- or professional-school degree, secondary-school degree, 
university degree, or data missing), alcohol consumption (none, 0.1 to 4.9, 5.0 to 14.9, 15.0 to 29.9, or ≥30 g per day), activity (inactive, mod-
erately inactive, moderately active, active, or data missing), and height (in quintiles). All covariates were entered into the models with the use 
of dummy coding.
‖  Relative risks in strata of smoking status were not adjusted for smoking status.
** Follow-up of 5 years or less indicates that follow-up time for all participants was censored after 5 years (i.e., only deaths occurring during the 
first 5 years were considered). Follow-up of more than 5 years indicates that person-time and incident events from the first 5 years of follow-
up were excluded (i.e., only deaths that occurred after more than 5 years of follow-up were included).
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associations were slightly but significantly stron-
ger among men than among women (P = 0.001 
for an interaction). When not adjusted for BMI, 
waist circumference and waist-to-hip ratio were 
significantly associated with the risk of death, 
with patterns similar to those observed for BMI 
(Fig. 1 and Table 2, and Table 3 in the Supple-
mentary Appendix).
After further adjustment for BMI, waist circum-
ference and waist-to-hip ratio showed a strong 
positive association with the risk of death (Table 2 
and Fig. 2, and Table 3 in the Supplementary 
Appendix). For a given BMI in men and women, 
a waist circumference that was 5 cm larger was 
associated with a risk of death that was increased 
by a factor of 1.17 (95% confidence interval [CI], 
1.15 to 1.20) among men and by a factor of 1.13 
(95% CI, 1.11 to 1.15) among women (P = 0.24 for 
the difference between men and women), and a 
waist-to-hip ratio that was 0.1 unit higher was 
associated with a risk that was increased by a 
factor of 1.34 (95% CI, 1.28 to 1.39) among men 
and by a factor of 1.24 (95% CI, 1.20 to 1.29) 
among women (P = 0.04 for the difference be-
tween men and women). In models that included 
waist circumference or waist-to-hip ratio, BMI re-
mained significantly associated with the risk of 
death (P<0.001). Hip circumference was not sig-
nificantly associated with the risk of death after 
adjustment for BMI (data not shown).
The associations of waist circumference and 
waist-to-hip ratio with the risk of death tended 
to be stronger among participants with a lower 
BMI, as compared with those who had a higher 
BMI (Table 2, and Table 3 in the Supplementary 
Appendix). On cross-classification, participants 
in the lowest third of BMI and the highest quin-
tile of waist circumference or waist-to-hip ratio, 
as compared with the reference group (partici-
pants in the middle third of BMI and the lowest 
quintile of waist circumference or waist-to-hip 
ratio), had the highest relative risk of death (Fig. 
3). The findings were similar when BMI was in-
stead categorized as 18.5 to less than 25.0, 25.0 
to less than 30.0, and 30.0 or greater (Fig. 1 in the 
Supplementary Appendix), although the ability to 
estimate relative risk precisely for the cross-classi-
fication of waist circumference by BMI was lim-
ited. Among men and women of normal weight, 
the relative risks in the highest quintile of waist 
circumference as compared with the lowest quin-
tile were 2.06 (95% CI, 1.32 to 3.20; P<0.001 for 
trend) and 1.79 (95% CI, 1.39 to 2.31; P<0.001 
for trend), respectively, and the relative risks in 
the highest quintile of waist-to-hip ratio as com-
pared with the lowest quintile were 1.79 (95% 
CI, 1.53 to 2.10; P<0.001 for trend) and 1.53 (95% 
CI, 1.34 to 1.75; P<0.001 for trend), respectively.
The addition of waist circumference or waist-
to-hip ratio to the regression model that included 
BMI slightly but significantly increased the C sta-
tistic (Table 4 in the Supplementary Appendix). 
As shown in Table 3, and in Table 5 in the Sup-
plementary Appendix, despite general agreement 
among the three regression models across the 
subject classifications (kappa values, 0.83 to 0.87), 
predicted risk categories changed substantially, 
and the model estimated the 5-year risk of death 
more accurately with the addition of waist cir-
cumference or waist-to-hip ratio than without 
these variables for men who had an absolute risk 
of 2.5% or greater and for women who had a risk 
of 1.25% or greater. The net reclassification index 
(which indicates the correct movement of partici-
pants across predefined risk categories, and thus 
depends on the choice of risk categories31) was 
significant only for the addition of waist-to-hip 
ratio to BMI among women. However, the inte-
grated discrimination index (which does not de-
pend on the choice of risk categories31) was 
highly significant for the addition of waist cir-
cumference or waist-to-hip ratio to BMI among 
participants of both sexes (Table 4 in the Supple-
mentary Appendix).
Subgroup Analyses
In subgroup analyses, the relative risk of death 
associated with a high BMI as compared with 
reference BMI levels was higher among partici-
pants who had never smoked than among former 
or current smokers, whereas the relative risk at 
low as compared with reference BMI levels was 
higher among former and current smokers (Ta-
ble 1). Among participants who had never smoked, 
the risk of death was lowest at a BMI of 24.5 for 
men and 23.9 for women (Fig. 2 and 3 in the 
Supplementary Appendix). Associations of waist 
circumference and waist-to-hip ratio with the risk 
of death tended to be slightly stronger among 
current smokers than among those who had 
never smoked, although the test for an interac-
tion was significant for waist circumference only 
among men (Table 2, and Table 3 in the Supple-
mentary Appendix). When participants were cross-
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classified, the associations within the group of 
participants who had never smoked were simi-
lar to those reported for the entire cohort (Fig. 4 
in the Supplementary Appendix). The association 
of a high BMI with an increased risk of death was 
stronger among younger men than among older 
men, and the association of general and abdom-
inal adiposity with the risk of death among men 
tended to be stronger for deaths occurring more 
than 5 years after enrollment than for deaths oc-
curring earlier. The relative risks of death asso-
ciated with a high BMI were strongest for circu-
latory causes of death, followed by other causes 
and neoplasms, whereas the relative risks associ-
ated with a high waist circumference or waist-to-
hip ratio were strongest for respiratory causes of 
death, followed by other causes (Tables 1 and 2; 
and Tables 3, 6, 7, and 8 and Fig. 5 in the Sup-
plementary Ap pendix).
We observed significant heterogeneity across 
centers among men but not among women for the 
association of BMI and of waist circumference 
with the risk of death (P = 0.001 for BMI and 
P = 0.004 for waist circumference). This heteroge-
neity was driven primarily by the center in Greece, 
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Figure 2. Adjusted Relative Risk of Death among Men and Women, According to Waist Circumference  
and Waist-to-Hip Ratio after Adjustment for BMI.
The relative risk of death in association with waist circumference and waist-to-hip ratio, after adjustment for BMI,  
is shown in Panel A for men and in Panel B for women. Solid lines indicate relative risks, and dashed lines indicate 
95% confidence intervals derived from restricted cubic spline regression, with knots placed at the 5th, 25th, 75th, 
and 95th percentiles of the sex-specific distribution of each anthropometric variable. The reference points for waist 
circumference and waist-to-hip ratio are the sex-specific medians of these variables. The graphs are truncated at the 
1st and 99th percentiles. Age was used as the underlying time variable in the regression models, with stratification 
by center and age at recruitment and additional adjustment for smoking status, educational level, alcohol consump-
tion, physical activity, height, and BMI. The relative risks are plotted on a logarithmic scale.
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the overall cohort. When the Greek center was 
excluded, the tests for heterogeneity were no 
longer significant (P>0.05), but the overall esti-
mates of relative risk did not change substan-
tially. When we performed sensitivity analyses in 
which we added the EPIC participants who had 
been excluded from our main study because their 
anthropometric measures were based only on self-
report, the overall relative risks did not change 
appreciably.
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Figure 3. Adjusted Relative Risk of Death among Men and Women According to Thirds of BMI and Quintiles of Waist Circumference  
or Waist-to-Hip Ratio.
The relative risk of death according to thirds of BMI and according to quintiles of waist circumfere ce and waist-to-hip ratio is shown in 
Panels A and B, respectively, for men and in Panels C and D, respectively, for women. The reference category consists of participants in 
the middle third of BMI and the bottom quintile of waist circumference or waist-to-hip ratio. Age was used as the underlying time variable 
in the regression models, with stratification according to center and age at recruitment and additional adjustment for smoking status, 
educational level, alcohol consumption, physical activity, and height. T or I bars indicate 95% confidence intervals for the relative risk of 
death. In Panel A, the upper boundary of the 95% confidence interval for men in the lowest third of BMI and the highest quintile of waist 
circumference was 4.60, and the upper boundary of the 95% confidence interval for men in the highest third of BMI and the lowest quin-
tile of waist circumference was 4.07. In Panel C, the lower boundary of the 95% confidence interval for women in the highest third of BMI 
and the lowest quintile of waist circumference was 0.35, and the lower boundary of the 95% confidence interval for women in the highest 
third of BMI and the second quintile of waist circumference was 0.45. The relative risks are plotted on a logarithmic scale. Q denotes quintile.
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Table 3. Expected and Observed 5-Year Risk of Death According to the Adjusted Model, with and without Waist Circumference.*
5-Year Risk According to Model with BMI
5-Year Risk According to Model  
with BMI and Waist Circumference
Total  
Reclassified
Men <2.5% 2.5 to <5.0% 5.0 to <7.5% ≥7.5%
<2.5%
Total participants (no.) 86,057 1,812 0 0
Participants classified in each stratum according to model  
with BMI and waist circumference (%)
97.94 2.06 0 0 2.06
Observed 5-yr risk (%) 0.92 2.37 — —
2.5 to <5.0%
Total participants (no.) 1,943 17,403 950 1
Participants classified in each stratum according to model  
with BMI and waist circumference (%)
9.57 85.74 4.68 0 14.25
Observed 5-yr risk (%) 2.16 3.49 5.47 0
5.0 to <7.5%
Total participants (no.) 0 892 4,998 577
Participants classified in each stratum according to model  
with BMI and waist circumference (%)
0 13.79 77.28 8.92 22.71
Observed 5-yr risk (%) — 4.71 6.98 7.80
≥7.5%
Total participants (no.) 0 2 563 5,640
Participants classified in each stratum according to model  
with BMI and waist circumference (%)
0 0.03 9.07 90.89 9.10
Observed 5-yr risk (%) — 0 7.82 14.22
Women <1.25% 1.25 to <2.50% 2.50 to <3.75% ≥3.75%
<1.25%
Total participants (no.) 179,814 3,227 0 0
Participants classified in each stratum according to model  
with BMI and waist circumference (%)
98.24 1.76 0 0 1.76
Observed 5-yr risk (%) 0.41 1.46 — —
1.25 to <2.50%
Total participants (no.) 2,933 25,996 1,497 6
Participants classified in each stratum according to model 
with BMI and waist circumference (%)
9.64 85.42 4.92 0.02 14.58
Observed 5-yr risk (%) 1.23 1.74 2.00 0
2.50 to <3.75%
Total participants (no.) 0 1,457 7,053 898
Participants classified in each stratum according to model  
with BMI and waist circumference (%)
0 15.49 74.97 9.55 25.04
Observed 5-yr risk (%) — 1.85 2.91 3.67
≥3.75%
Total participants (no.) 0 4 864 8,334
Participants classified in each stratum according to model  
with BMI and waist circumference (%)
0 0.04 9.39 90.57 9.43
Observed 5-yr risk (%) — 0 3.36 6.89
* The multivariable logistic model included age (in 5-year categories), center, smoking status (never smoked, former smoker [stopped ≥10 or 
<10 years ago or time since stopping unknown], current smoker [<15, 15 to 24, or ≥25 cigarettes per day or number unknown], or data miss-
ing), educational level (no school degree, primary-school degree, technical- or professional-school degree, secondary-school degree, univer-
sity degree, or data missing) alcohol consumption (none, 0.1 to 4.9, 5.0 to 14.9, 15.0 to 29.9, or ≥30 g per day), activity (inactive, moderately 
inactive, moderately active, active, or data missing), height (in quintiles), and BMI (<18.5, 18.5 to <21.0, 21.0 to <23.5, 23.5 to <25.0, 25.0 to 
<26.5, 26.5 to <28.0, 28.0 to <30.0, 30.0 to <35.0, or ≥35.0).
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Discussion
In this large European cohort study, general and 
abdominal adiposity were independently related 
to the risk of death. The associations of BMI with 
the risk of death were J-shaped, with higher risks 
of death observed in the lower and upper BMI 
categories than in the middle categories. In con-
trast, once general adiposity was adjusted for, ab-
dominal fat distribution was positively associated 
with the risk of death. These associations tended 
to be stronger among participants with a lower BMI 
than among those with a higher BMI. Thus, mea-
surement of both general and abdominal adipos-
ity provides a better assessment of the risk of death, 
particularly among people with a lower BMI.
The most appropriate adiposity markers for as-
sessing the risk of disease and death are debat-
ed.4,32 Waist circumference and BMI are highly 
correlated and when considered individually re-
flect the extent of both abdominal and general 
obesity. However, the large sample in our study 
enabled us to estimate with sufficient precision 
the effect of abdominal adiposity on the risk of 
death independently of general obesity. The waist-
to-hip ratio is less strongly related to BMI than 
is waist circumference and is therefore a more 
specific surrogate for fat distribution. Although 
the waist-to-hip ratio may therefore be preferred 
as a predictor of the risk of death, in addition to 
BMI, because it has less potential for collinearity, 
the use of waist circumference has been predom-
inantly proposed in the past decade, largely be-
cause waist circumference is easier to measure 
and to interpret than the waist-to-hip ratio.2,33
The current results underscore the importance 
of assessing the distribution of body fat even 
among persons of normal weight and challenge 
the use of cutoff points to define abdominal obe-
sity, at least when they are used to predict the 
risk of death.2,34 Our finding of a positive asso-
ciation between waist circumference and the risk 
of death among participants of normal weight 
may also explain why studies have been unable 
to show a linear relationship between BMI and 
the risk of death across the entire range of BMI 
values.
Like previous studies, our study showed that 
general obesity was more strongly related to the 
risk of death among participants who had never 
smoked, whereas underweight was more strongly 
related to the risk of death among current smok-
ers; these results may reflect the finding that 
smokers have a lower body weight but a higher 
risk of death than nonsmokers.15,17,35 In contrast, 
after adjustment for BMI, the association of waist 
circumference with the risk of death was stron-
ger among smokers. Smokers tend to have a 
metabolically more adverse fat-distribution pro-
file, with higher central adiposity, than nonsmok-
ers.36 Older persons may be more likely than 
younger persons to have underlying but undiag-
nosed chronic diseases that are related to a lower 
BMI and an increased risk of death. Obesity ap-
peared to be more strongly related to the risk of 
death among younger men than among older 
men, whereas no such difference was observed 
among women. The reasons for these sex differ-
ences are unclear and may reflect biologic factors 
or the play of chance. It is also important to note 
that the absolute risk of death in the reference 
category varied across subgroups. For example, 
although general adiposity was more strongly re-
lated to the risk of death among people who had 
never smoked than among current smokers, the 
absolute risk of death was higher among current 
smokers (data not shown).
Adipose tissue, particularly tissue from vis-
ceral-fat deposits, secretes potential mediators in 
the development of chronic diseases1; this pro-
cess may explain why abdominal fat distribution 
was related to the risk of death independently of 
BMI. Body mass is more closely related to the 
amount of visceral fat in men than in women,37 
which may be among the reasons that the relative 
risk of death among participants with a high BMI 
was higher for men than for women. The in-
creased risk of death among participants with a 
low BMI could be the result of low muscle mass, 
since even at a low BMI, waist circumference 
was positively related to the risk of death. As in 
the present study, a recent report suggested that 
the increase in the risk of death associated with 
a low BMI is driven primarily by respiratory and 
other causes, whereas the increased risk associ-
ated with a high BMI is driven by cardiovascular 
causes and cancer.18 Although abdominal adipos-
ity is related to chronic inflammation, which may 
lead to the development of chronic bronchitis and 
other diseases, the mechanisms for the strong 
positive associations with deaths from respira-
tory and other causes are unclear.38
Our study has certain limitations. Although 
people who had a history of cancer, heart dis-
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ease, or stroke were excluded, our analysis may 
have included a number of participants who had 
other serious diseases that could potentially con-
found the observed associations. Nevertheless, we 
believe that the number of participants with 
other serious diseases at baseline was small be-
cause it is unlikely that such persons would de-
cide to participate in a long-term cohort study. 
This assumption is indirectly supported by the 
low prevalence of cancer, heart disease, and 
stroke in the original EPIC study population. The 
association of adiposity with the risk of death 
may vary with a longer follow-up period; how-
ever, it would probably become stronger, as sug-
gested by our sensitivity analysis.
The improvement in the prediction of risk by 
the addition of waist circumference or waist-to-
hip ratio to BMI was small with respect to the 
C statistic, as would be expected, since the C sta-
tistic is very insensitive to the detection of true 
predictors.30,39 In contrast, and clinically more 
important,30 the addition of waist circumference 
or waist-to-hip ratio to BMI more accurately 
stratified participants into higher-risk and lower-
risk categories.
The causes of heterogeneity across centers, 
driven by the Greek cohort, are unclear and may 
reflect differences in the way in which anthropo-
metric measurements were performed, biologic 
diversity among different populations, or the play 
of chance. Nevertheless, the relative-risk estimates 
for the overall cohort did not change substan-
tially when the participants from Greece were 
excluded from the analysis.
The use of overall mortality and broad cate-
gories of cause-specific mortality in our analysis 
of risk may limit interpretations of the causes of 
the associations. Nevertheless, such research is 
crucial for estimating whether reductions in the 
prevalence of adiposity would affect a popula-
tion’s mortality. Although the level of accuracy 
for the coding of deaths from cancer and circu-
latory causes on the basis of information from 
death certificates is high, it may be lower for the 
coding of deaths from respiratory causes.40 There-
fore, the analyses according to the cause of 
death have to be interpreted cautiously. In addi-
tion, imperfect follow-up procedures may have 
resulted in the erroneous classification of some 
deceased participants as alive. However, we be-
lieve that this number was negligibly small, and, 
given the large sample, the reduction in sensitiv-
ity would have no substantial effect on the esti-
mates of relative risk. Finally, although we adjust-
ed our analyses for several variables, because of 
the observational nature of the study, we cannot 
exclude the possibility of residual confounding.
In conclusion, the findings of our study sug-
gest that general and abdominal adiposity are 
both associated with the risk of death. The re-
sults support the use of waist circumference or 
waist-to-hip ratio in addition to BMI in the assess-
ment of the risk of death, particularly among 
persons with a low BMI.
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